← FDA Drug Approvals (Drugs@FDA)

SUMATRIPTAN SUCCINATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: NORVIUM BIOSCIENCE · Approved 2014-04-14

Drug application

FDA Application #

ANDA203322

Application type

Abbreviated New Drug Application (Generic)

Brand name

SUMATRIPTAN SUCCINATE

Generic name

Sumatriptan Succinate

Active ingredients

SUMATRIPTAN SUCCINATE

Dosage form

INJECTABLE

Route

SUBCUTANEOUS

Marketing status

Discontinued

Sponsor

NORVIUM BIOSCIENCE

First approval

2014-04-14

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown